维普资讯
发表评论我要收藏点击“我要推荐”按钮复制地址,将本页推荐给别人看,自己就可以获得积分奖励!点击“我要推荐”按钮复制地址,推荐文章给别人看,自己就可以获得积分奖励。

胃食管反流病的初步诊断及非药物干预措施的探讨

免费下载
[全文大小:145 K]

段英伟[1] 王晶桐[2]

[1]北京市西城区展览路医院,北京100044 [2]北京大学人民医院,北京100044

北京医学
订阅本刊
国际标准刊号:ISSN 0253-9713
国内统一刊号:CN 11-2273

摘  要:

目的探讨社区范围内胃食管反流病(gastroesophageal reflux disease,GERD)非药物干预的效果及可行性。方法将筛选出的280例用反流性疾病诊断问卷(耐信量表,RDQ)初步确诊为GERD的患者,分为三组,非药物干预组85例,药物干预组111例,对照组84例。收集病史资料,记录观察期间RDQ值的变化。结果三组间RDQ评分有显著性差异,药物干预组症状消失者停药半年后复发46例,占总药物治疗人数的41.44%.而非药物干预组症状消失者仅有2例复发,且程度较轻。结论从近期疗效看非药物干预及药物干预皆可明显控制症状,虽然药物治疗控制症状效果好于非药物干预。但从长远看存在费用高及复发率高的情况,提示在社区范围内控制GERD疾病非药物干预是一个有效的、经济可行的好方法。[著者文摘]

文章出处:

《北京医学》-2007年29卷10期 -607-609页

Beijing Medical Journal

栏目信息:

论著

分 类 号:

R544.1

相关文章:

参考文献(5篇) 耦合文献(201篇)  主题相关

[参考文献]

The effect and feasibility of non-drug intervention of the gastroesophageal reflux disease in community

DUA N Y ing-wei, WANG Jing-tong (Zhanlanlu Hospital, Beijing 100044)

Abstract:

objective To explore the effect and feasibility of non-drug intervention in gastroesophageal reflux disease (GERD) in community. Methods 280 patients diagnosed with Nexium RDQ were divided into three groups,the non-drug intervention group(n=85), the drug intervention group(n=111)and the control group (n=84). The data of these patients were collected and the clinical effect of Nexium RDQ was assessed. Results There was a significant difference on Nexium RDQ between the three groups. Forty-six cases had reccurrent in the drung intervention group and 2 cases had reccurrent in non-drug intervention group during half a year follow-up. Conclusions Both non-drug intervention and drug intervention can control the symptoms of GERD, although drug intervention is better than non-drug intervention. However in a long run drug intervention has a higher recurrence and is more expensive. So non-drug intervention is an effective and feasible method for the treatment of gastroesophageal reflux disease (GERD) in community.[著者文摘]

Key words:

Community Gastroesophageal reflux disease(GERD) Non-drug intervention

收稿日期: 2007-05-15
更多评论>>文章评论
你是匿名用户 登录 | 注册 验证码 刷新
中国业务群个人门户,免费下载!
更多>>相关文章
天元数据 维普资讯 版权所有 Copyright © 2001-2008 cqvip.com Inc. All rights reserved.
渝ICP证 B2-20050021  违法和不良信息举报中心
建议使用:1024x768分辨率,16位以上颜色